Holdings

Remedium Capital Partners, LLC

As of Sep 30, 2026, Remedium Capital Partners, LLC reported 4 positions worth US$213M. Largest: Spyre Therapeutics, Inc., Oruka Therapeutics, Inc. and Jade Biosciences, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Spyre Therapeutics, Inc.1.16MUS$103M−304KSep 30, 2026
Oruka Therapeutics, Inc.954KUS$79.5M−612KSep 30, 2026
Jade Biosciences, Inc.1.81MUS$25.4M+230KSep 30, 2026
Crescent Biopharma, Inc.361KUS$5.27Mno changeSep 30, 2026